

Author: Michael E. Ernst
Publisher: Adis International
ISSN: 1172-7047
Source: CNS Drugs, Vol.18, Iss.11, 2004-01, pp. : 755-756
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Ropinirole: A Viewpoint by Thomas C. Wetter
CNS Drugs, Vol. 18, Iss. 11, 2004-01 ,pp. :


Darbepoetin Alfa: A Viewpoint by Michael Hedenus
By Hedenus M.
Drugs, Vol. 63, Iss. 11, 2003-01 ,pp. :


Transdermal Oxybutynin: A Viewpoint by Michael Chancellor
Drugs & Aging, Vol. 20, Iss. 11, 2003-01 ,pp. :


Sorafenib in Advanced Renal Cancer: A Viewpoint by Michael Staehler
Drugs, Vol. 67, Iss. 3, 2007-01 ,pp. :


Budesonide/Formoterol: A Viewpoint by Michael Roth1,2
By Roth M.
Drugs, Vol. 64, Iss. 4, 2004-01 ,pp. :